BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16455347)

  • 1. 7. Control of allergic airway inflammation through immunomodulation.
    Corry DB; Kheradmand F
    J Allergy Clin Immunol; 2006 Feb; 117(2 Suppl Mini-Primer):S461-4. PubMed ID: 16455347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibitory effect of suplatast tosilate on eosinophil migration].
    Kobayashi Y; Nagata M; Yamamoto H; Sakamoto Y
    Arerugi; 2000 Jul; 49(7):600-3. PubMed ID: 10944827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in suplatast tosilate research.
    Sano Y; Yamada H
    Clin Exp Allergy; 2007 Jul; 37(7):970-2. PubMed ID: 17581190
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma.
    Tanaka A; Minoguchi K; Samson KT; Oda N; Yokoe T; Tazaki T; Yamamoto Y; Yamamoto M; Ohta S; Adachi M
    Clin Exp Allergy; 2007 Jul; 37(7):1083-9. PubMed ID: 17581203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of suplatast tosilate on goblet cell metaplasia in patients with asthma.
    Hoshino M; Fujita Y; Saji J; Inoue T; Nakagawa T; Miyazawa T
    Allergy; 2005 Nov; 60(11):1394-400. PubMed ID: 16197471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suplatast tosilate alters DC1/DC2 balance in peripheral blood in bronchial asthma.
    Yokomura K; Suda T; Matsuda H; Hashizume H; Asada K; Suzuki K; Chida K
    J Asthma; 2005 Sep; 42(7):567-70. PubMed ID: 16169790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of suplatast tosilate, a Th2 cytokine inhibitor based on the Th1/Th2 ratio for allergic disease in children: a retrospective study.
    Yoshihara S; Fukuda H; Arisaka O
    Arzneimittelforschung; 2011; 61(7):421-4. PubMed ID: 21899211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of suplatast tosilate on antileukotriene non-responders with mild-to-moderate persistent asthma.
    Wada M; Nagata S; Kudo T; Shimizu T; Yamashiro Y
    Allergol Int; 2009 Sep; 58(3):389-93. PubMed ID: 19542765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cough-variant asthma successfully treated with suplatast tosilate].
    Fujimori K; Suzuki E; Arakawa M
    Arerugi; 1998 Jul; 47(7):694-7. PubMed ID: 9780445
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful treatment of eosinophilic gastroenteritis with suplatast tosilate.
    Shirai T; Hashimoto D; Suzuki K; Osawa S; Aonahata M; Chida K; Nakamura H
    J Allergy Clin Immunol; 2001 May; 107(5):924-5. PubMed ID: 11344364
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of suplatast tosilate on allergic eosinophilic airway inflammation in patients with mild asthma.
    Sano Y; Suzuki N; Yamada H; To Y; Ogawa C; Ohta K; Adachi M
    J Allergy Clin Immunol; 2003 May; 111(5):958-66. PubMed ID: 12743558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale for new treatments aimed at IgE immunomodulation.
    Stokes J; Casale TB
    Ann Allergy Asthma Immunol; 2004 Sep; 93(3):212-7; quiz 217-9, 271. PubMed ID: 15478378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newer therapies for asthma: a focus on anti-IgE.
    Babu KS; Holgate ST
    Indian J Chest Dis Allied Sci; 2002; 44(2):107-15. PubMed ID: 12026249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of suplatast tosilate on airway hyperresponsiveness and inflammation in asthma patients.
    Yoshida M; Aizawa H; Inoue H; Matsumoto K; Koto H; Komori M; Fukuyama S; Okamoto M; Hara N
    J Asthma; 2002 Sep; 39(6):545-52. PubMed ID: 12375715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omalizumab is more effective than suplatast tosilate in the treatment of Japanese cedar pollen-induced seasonal allergic rhinitis.
    Nagakura T; Ogino S; Okubo K; Sato N; Takahashi M; Ishikawa T
    Clin Exp Allergy; 2008 Feb; 38(2):329-37. PubMed ID: 18070163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of an orally active Th2 cytokine inhibitor, suplatast on "atopic cough" tosilate.
    Ishiura Y; Fujimura M; Yamamoto H; Nobata K; Ishiguro T; Ogawa H; Myou S
    Arzneimittelforschung; 2008; 58(6):297-302. PubMed ID: 18677972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytokine production by peripheral blood mononuclear cells in bronchial asthma treated with suplatast tosilate].
    Yamasawa H; Oshikawa K; Sugiyama Y
    Arerugi; 2001 Jun; 50(6):513-9. PubMed ID: 11517513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of non-episodic angioedema associated with eosinophilia with suplatast tosilate, an anti-allergic selective Th2 cytokine inhibitor.
    Hashizume H; Umayahara T
    Eur J Dermatol; 2014; 24(2):250-2. PubMed ID: 24723649
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of suplatast tosilate on the patients with atopic dermatitis--relationship between clinical symptoms and immunological parameters].
    Higashi N; Niimi Y; Aoki M; Fujimoto K; Suzuki K; Numano K; Kawana S
    Arerugi; 2003 Nov; 52(11):1065-73. PubMed ID: 14685038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic eosinophilic pneumonia successfully treated with suplatast tosilate].
    Hamada H; Sakatani M; Nishioka M; Akira M; Yamamoto S; Ueda E; Okano Y; Nakamura Y; Sone S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jun; 35(6):692-7. PubMed ID: 9294307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.